AllerStrength

FDA Statement of Identity

Dietary Supplement

General Statements: All Other Content

Highly bioavailable

Formula re: Contains

EMIQ 17x Quercetin

Suggested/Recommended/Usage/Directions

Suggested use: 1 tablet twice daily.

Precautions re: Pregnant or Nursing or Prescription Medications

Note: If you are pregnant, may become pregnant, or breastfeeding, consult your health care professional before using this product.

Storage

Store in a cool, dry place.

Precautions re: All Other

Do not use if either tamper-evident seal is broken or missing.

Precautions re: Children

Keep out of the reach of children.

Formulation re: Vegetarian/Vegan

Suitable for Vegetarians.

Formulation re: Does NOT Contain

Contains no yeast, dairy, egg, gluten, soy or wheat. Contains no sugar, starch, salt, preservatives, or artificial color, flavor or fragrance.

Formula re: Contains

Enzymatically modified isoquercitrin is a type of quercetin that includes additional glucose molecules for increased solubility and bioavailability. This advanced springtime support product offers quick absorption. Enzymatically modified isoquercitrin was demonstrated to have 17 times greater bioavailability than quercetin itself in one clinical trial. Its core compound, quercetin, was shown in preliminary, in-vitro research to inhibit histamine release. Enzymatically modified isoquercitrin administered at the dose supplied in this product has been clinically demonstrated to maintain eye health during periods of seasonal discomfort.

Brand IP Statement(s) re: (c), (TM), (SM)

EMIQ is a registered trademark of San-Ei Gen F.F.I., and is used under license from Theravalues Corporation.

FDA Disclaimer Statement

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

General: Product/Version Code

SN2686 REV E166